The immunological effects of extracorporeal photopheresis unraveled: induction of tolerogenic dendritic cells in vitro and regulatory T cells in vivo
- PMID: 15818329
- DOI: 10.1097/01.tp.0000157278.02848.c7
The immunological effects of extracorporeal photopheresis unraveled: induction of tolerogenic dendritic cells in vitro and regulatory T cells in vivo
Abstract
Extracorporeal photopheresis (ECP) may represent an alternative to immunosuppression, as a means of reducing rejection after thoracic organ transplantation. The mechanism by which ECP exerts its protective effects has, until now, remained elusive. We analyzed peripheral blood mononuclear cells of four children with chronic heart and lung transplant rejection, who received ECP in addition to conventional immunosuppressive treatment. The effects of ECP were evaluated at each cycle, comparing blood samples from the same patient collected before and after treatment. In vitro, peripheral blood mononuclear cells treated with ECP undergo apoptosis and are phagocytosed by immature dendritic cells, which, in turn, acquire a tolerogenic phenotype. The frequency of T cells, with a regulatory phenotype and strong suppressive activity, was significantly increased in the blood of ECP-treated patients. The immunomodulatory effects of ECP may be explained by its ability to increase the frequency of regulatory T cells with inhibitory action on transplant immune rejection.
Similar articles
-
[Immunological monitoring of the efficacy of extracorporeal photopheresis for prevention of kidney transplant rejection].Urologiia. 2020 Sep;(4):73-78. Urologiia. 2020. PMID: 32897018 Russian.
-
Indication-specific immunomodulatory effects of extracorporeal photopheresis: A pilot study in heart transplanted patients.J Clin Apher. 2018 Oct;33(5):591-599. doi: 10.1002/jca.21647. Epub 2018 Sep 3. J Clin Apher. 2018. PMID: 30176056
-
Extracorporeal photopheresis: from solid organs to face transplantation.Transpl Immunol. 2009 Jul;21(3):117-28. doi: 10.1016/j.trim.2009.04.005. Epub 2009 May 3. Transpl Immunol. 2009. PMID: 19409991 Review.
-
Immune Monitoring Assay for Extracorporeal Photopheresis Treatment Optimization After Heart Transplantation.Front Immunol. 2021 Aug 10;12:676175. doi: 10.3389/fimmu.2021.676175. eCollection 2021. Front Immunol. 2021. PMID: 34447372 Free PMC article.
-
Extracorporeal photopheresis after heart transplantation.Immunotherapy. 2014;6(8):927-44. doi: 10.2217/imt.14.69. Immunotherapy. 2014. PMID: 25313571 Review.
Cited by
-
Management of Chronic Graft-vs.-Host Disease in Children and Adolescents With ALL: Present Status and Model for a Personalised Management Plan.Front Pediatr. 2022 Feb 18;10:808103. doi: 10.3389/fped.2022.808103. eCollection 2022. Front Pediatr. 2022. PMID: 35252060 Free PMC article.
-
Chronic Lung Allograft Dysfunction: Clinical Manifestations and Immunologic Mechanisms.Transplantation. 2025 Mar 1;109(3):454-466. doi: 10.1097/TP.0000000000005162. Epub 2024 Aug 6. Transplantation. 2025. PMID: 39104003 Review.
-
Pilot study of a new online extracorporeal photopheresis system in patients with steroid refractory or dependent chronic graft vs host disease.J Clin Apher. 2020 Aug;35(4):342-350. doi: 10.1002/jca.21804. Epub 2020 Jul 8. J Clin Apher. 2020. PMID: 32640498 Free PMC article.
-
Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation.Bone Marrow Transplant. 2010 Jun;45(6):1068-76. doi: 10.1038/bmt.2009.307. Epub 2009 Nov 16. Bone Marrow Transplant. 2010. PMID: 19915634 Free PMC article. Clinical Trial.
-
Immunological monitoring of extracorporeal photopheresis after heart transplantation.Clin Exp Immunol. 2014 Apr;176(1):120-8. doi: 10.1111/cei.12254. Clin Exp Immunol. 2014. PMID: 24329680 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources